CLINICAL_TRIALS
trial_result
· 2014-03-20
Clinical Trial Update: Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy [Phase 3]
Summary
A Phase 3 study comparing insulin lispro versus insulin aspart in people with type 2 diabetes on insulin pump therapy completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-03-20